Mostrar el registro sencillo de la publicación

dc.contributor.authorValenzuela-Hormazabal, Paulina
dc.contributor.authorSepúlveda, Romina V.
dc.contributor.authorAlegría-Arcos, Melissa
dc.contributor.authorValdés-Muñoz, Elizabeth
dc.contributor.authorRojas-Pérez, Víctor
dc.contributor.authorGonzález-Bonet, Ileana
dc.contributor.authorSuardíaz, Reynier
dc.contributor.authorGalarza, Christian
dc.contributor.authorMorales, Natalia
dc.contributor.authorLeddermann, Verónica
dc.contributor.authorCastro, Ricardo I.
dc.contributor.authorBenso, Bruna
dc.contributor.authorUrra, Gabriela
dc.contributor.authorHernández-Rodríguez, Erix W.
dc.contributor.authorBustos, Daniel
dc.date.accessioned2024-04-16T19:17:28Z
dc.date.available2024-04-16T19:17:28Z
dc.date.issued2024
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/5310
dc.description.abstractHelicobacter pylori (Hp) infections pose a global health challenge demanding innovative therapeutic strategies by which to eradicate them. Urease, a key Hp virulence factor hydrolyzes urea, facilitating bacterial survival in the acidic gastric environment. In this study, a multi-methodological approach combining pharmacophore- and structure-based virtual screening, molecular dynamics simulations, and MM-GBSA calculations was employed to identify novel inhibitors for Hp urease (HpU). A refined dataset of 8,271,505 small molecules from the ZINC15 database underwent pharmacokinetic and physicochemical filtering, resulting in 16% of compounds for pharmacophore-based virtual screening. Molecular docking simulations were performed in successive stages, utilizing HTVS, SP, and XP algorithms. Subsequent energetic re-scoring with MM-GBSA identified promising candidates interacting with distinct urease variants. Lys219, a residue critical for urea catalysis at the urease binding site, can manifest in two forms, neutral (LYN) or carbamylated (KCX). Notably, the evaluated molecules demonstrated different interaction and energetic patterns in both protein variants. Further evaluation through ADMET predictions highlighted compounds with favorable pharmacological profiles, leading to the identification of 15 candidates. Molecular dynamics simulations revealed comparable structural stability to the control DJM, with candidates 5, 8 and 12 (CA5, CA8, and CA12, respectively) exhibiting the lowest binding free energies. These inhibitors suggest a chelating capacity that is crucial for urease inhibition. The analysis underscores the potential of CA5, CA8, and CA12 as novel HpU inhibitors. Finally, we compare our candidates with the chemical space of urease inhibitors finding physicochemical similarities with potent agents such as thiourea.es_CL
dc.language.isoenes_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceInternational Journal of Molecular Sciences, 25(4),1968es_CL
dc.subjectComputer-aided drug designes_CL
dc.subjectStructure-based virtual screeninges_CL
dc.subjectPharmacophore-based virtual screeninges_CL
dc.subjectMolecular dynamics simulationses_CL
dc.subjectADMETes_CL
dc.subjectUreasees_CL
dc.subjectHelicobacter pylories_CL
dc.titleUnveiling novel urease inhibitors for Helicobacter pylori: A multi-methodological approach from virtual screening and ADME to molecular dynamics simulationses_CL
dc.typeArticlees_CL
dc.ucm.facultadFacultad de Ciencias Agrarias y Forestaleses_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.urimdpi.com/1422-0067/25/4/1968es_CL
dc.ucm.doidoi.org/10.3390/ijms25041968es_CL


Ficheros en la publicación

FicherosTamañoFormatoVer

No hay ficheros asociados a esta publicación.

Esta publicación aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo de la publicación

Atribución-NoComercial-SinDerivadas 3.0 Chile
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile